From: An Expanding Role for Interleukin-1 Blockade from Gout to Cancer
Disease | References |
---|---|
FMF | 138-151 |
FCAS | 115,152,153 |
MWS | 30,104,154–161 |
NLRP12 autoinflammatory syndrome | 162 |
NOMID | 23,30,102,105,106,163–166 |
TRAPS | 167–173 |
Hyperimmunoglobulin D syndrome (HIDS) | 174–179 |
PAPA syndrome | 180–186 |
Pseudoangiomatous stromal hyperplasia (PASH) | 180,187 |
Deficiency of the IL-1 receptor antagonist (DIRA) | 188–190 |
Blau syndrome (granulomatous arthritis) | 191,192 |
Mevalonate kinase deficiency | 193 |
Majeed syndrome | 194 |